Urology

Medicine & Life Sciences

1. Prostatic Neoplasms 100%
2. Castration 60%
3. Androgen Receptors 44%
4. Androgens 39%
5. Renal Cell Carcinoma 30%
6. Urinary Bladder Neoplasms 22%
7. Docetaxel 19%
8. Survival 18%
9. Neoplasms 17%
10. Nephrectomy 16%
11. Therapeutics 16%
12. Y-Box-Binding Protein 1 15%
13. Prostatectomy 14%
14. Japan 13%
15. MDV 3100 13%
16. cabazitaxel 12%
17. Progression-Free Survival 11%
18. Prostate-Specific Antigen 11%
19. Urinary Bladder 10%
20. Prostate 10%
21. Drug Therapy 10%
22. Growth 9%
23. Kidney 9%
24. Testosterone 9%
25. Recurrence 8%
26. Carcinoma 8%
27. Oxidative Stress 8%
28. Sorafenib 7%
29. Prostatic Hyperplasia 6%
30. Cyclophosphamide 6%
31. Confidence Intervals 6%
32. Nephroureterectomy 6%
33. Kidney Neoplasms 6%
34. Genes 6%
35. taxane 6%
36. Allogeneic Cells 6%
37. Serum 6%
38. Lymph Node Excision 6%
39. abiraterone 5%
40. Hormones 5%
41. Neoplasm Grading 5%
42. Cisplatin 5%
43. Urologic Neoplasms 5%
44. Lymph Nodes 5%
45. Databases 5%
46. Smooth Muscle 5%